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Abstract 
Background: Plasmodium falciparum gametocytes are vital to sustaining malaria transmission. Parasite densities, 
multiplicity of infection as well as asexual genotype are features that have been found to influence gametocyte pro‑
duction. Measurements of the prevalence of Plasmodium sp. gametocytes may serve as a tool to monitor the success 
of malaria eradication efforts.
Methods: Whole blood was collected from 112 children aged between 6 months and 13 years with uncomplicated 
P. falciparum malaria attending three health facilities in southern Ghana from June to August, 2014 before (day 0) and 
4 days after completion of anti‑malaria drug treatment (day 7). Malaria parasites were observed by microscopy and 
polymerase chain reaction (PCR); submicroscopic gametocyte carriage was measured by a Pfs25 (PF3D7_1031000) 
mRNA real time reverse transcriptase polymerase chain reaction (RT‑PCR). Parasite genotyping was performed 
on gDNA extracted from dried filter paper blood blots by amplification of the polymorphic regions of msp1 
(PF3D7_0930300) and msp2 (PF3D7_0206800) using PCR.
Results: Microscopy estimated 3.1% (3/96) of the total population to carry gametocytes on day 0, which decreased 
to 2.1% (2/96) on day 7. In contrast, reverse transcriptase‑real time PCR (RT‑PCR) analysis of a subset of 35 samples 
estimated submicroscopic gametocyte carriage to be as high as 77% (27/35) using primers specific for Pfs25 (CT < 35) 
on day 0 and by day 7 this only declined to 60% (21/35). Genotyping the msp2 gene identified higher levels of MOI 
than the msp1 gene.
Conclusions: Although below detection by microscopy, gametocyte prevalence at submicroscopic levels are high in 
this region and emphasize the need for more effective elimination approaches like the development of transmission‑
blocking vaccines and safer gametocytocidal drugs.
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Background
In Ghana, malaria is still one of the leading causes of 
outpatient attendance and mortality in children under 
the age of 5  years [1], despite enhanced control efforts. 
Plasmodium falciparum, the most lethal of the five spe-
cies that cause human malaria, is responsible for about 
90% of all malaria cases in Ghana [2]. Malaria transmis-
sion requires the production of sexual stage parasites 
that are stimulated to fertilize after being taken up dur-
ing a blood meal by a mosquito [3]. The zygote contin-
ues development in the mosquito producing an oocyst 
containing sporozoites that can initiate an infection in 
humans during a subsequent blood meal. Sexual repro-
duction coupled with high genetic diversity in the local 
parasite population and concurrent infections with poly-
morphic parasite lines provides genetic flexibility that 
allow adaptation to immune and drug pressure [4] and 
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also influences malaria transmission success [5]. For 
example, an increase in the rate of sexual recombination 
has been found to give rise to parasites with different drug 
resistant profiles [6–9]. Low haematocrit and history of 
prolonged illness have been associated with gametocyte 
prevalence detected using microscopy [10]. Genetic fac-
tors are also likely to play a role since gametocyte produc-
tion and mosquito infectivity have been shown to vary 
between parasite lines [11–14]. Together the dynamics of 
parasite diversity and gametocyte production have impor-
tant implications for the acquisition of immunity by the 
host and the spread of drug resistant parasites. However, 
monitoring gametocyte production in the human host is 
complicated by low production levels and sequestration 
of immature gametocytes during the 10–12 days required 
for the development of stage V P. falciparum gametocytes. 
Only mature stage V gametocytes circulate and can be 
detected in peripheral blood. Previous work in East Africa 
and Asia demonstrated that gametocytes are resistant 
to artemisinin-based combination therapy (ACT) and, 
consequently, patients remain infectious for over a week 
after asexual parasite clearance [15, 16]. The role of the 
immune response in controlling gametocyte levels in the 
human host has not been well established [17]. However, 
Pfs230 and Pfs48/45 are expressed on the gametocyte sur-
face during development in the RBC in the human host 
[18–20] and anti-Pfs230 and Pfs48/45 antibodies are gen-
erated during a natural infection [19–24]  and thus can 
serve as a marker for recent gametocyte exposure.
This study assessed the prevalence of submicro-
scopic gametocytes levels and asexual parasite diversity 
in patients aged between 6  months and 13  years with 
uncomplicated P. falciparum infections. Understanding 
these patterns is critical to the development of interven-
tion strategies in high transmission areas. The persistence 
of gametocytes in children with uncomplicated malaria 




The study was approved by the Institutional Review 
Board of the Noguchi Memorial Institute for Medical 
Research (NMIMR) and Ghana Health Services. Before 
recruitment each parent/guardian was informed of the 
objectives, methods, anticipated benefits and potential 
hazards of the study. The parents/guardians were encour-
aged to ask questions about any aspect of the study that 
was unclear to them and informed about their liberty 
to withdraw their children at any time without penalty. 
Children were enrolled only after written parental con-
sent had been obtained. All patient information is treated 
as confidential.
Study site and population
The study was conducted in three health facilities, the 
Ghana Atomic Energy Commission (GAEC) Clinic in 
Accra, Ewim Health Centre and Elmina Health Cen-
tre, both in Cape Coast. Cape Coast (05°05′ N, 01°15′ 
W), an urban setting, has an estimated population of 
227,269 and lies in the Coastal savannah region (Fig. 1). 
Cape Coast, which is the capital of the Central Region, 
is about 165  km from Accra. Malaria transmission in 
this area is perennial with most of the disease occurring 
during the major rainy season in June/July. Accra (05°35′ 
N, 00°06′ W), an urban setting has an estimated popu-
lation of 2,291,352. Accra is the capital city of Ghana 
with a total land area of 201 sq km. Accra is one of the 
most populated and fast growing metropolis in Africa 
with an annual growth rate of 4.3% [25] and lies in the 
coastal savannah region. Malaria transmission in this 
area is also perennial with most of the disease occurring 
during the major rainy season in June/July. The study 
group comprised of 112 children between the ages of 
4 months–13 years, where 55 participants where between 
8 and 60 months and the rest between 72 and 156 months 
(Table 1). The malaria patients enrolled in this study were 
prescribed ACT (artemether-lumefantrine) at the health 
centre, BUT there was no evaluation/monitoring of ACT 
intake.
Sampling
A total of 112 samples were collected from patients 
aged 6  months–13  years, who visited the health centre 
with uncomplicated malaria from June to August 2014. 
Children who were found to be P. falciparum positive 
by microscopy were enrolled after parental consent was 
obtained and in accordance with the study inclusion cri-
teria [26]. Sixteen of the children did not return for the 
1 week follow up visit. Prior to treatment (day 0) and dur-
ing the 7 day follow up visit (day 7), 2 ml of venous blood 
was collected into EDTA vacutainer tubes and an aliquot 
spotted onto filter paper (Whatman® 3  mm). The filter 
paper was air-dried and stored desiccated at room tem-
perature. The EDTA samples were immediately centri-
fuged and the plasma collected and saved for future use. 
One hundred microlitres of pelleted cells were preserved 
in 500 µl of Trizol (Tri Reagent, Invitrogen). All the sam-
ples were transported to the NMIMR for analysis.
Parasite density
Thin and thick blood smears were prepared from capil-
lary blood collected on day 0 and venous blood collected 
on day 7. The thin smears were used for Plasmodium 
species identification and thick smears used for parasite 
(asexual and sexual) density estimation by using 100X 
oil immersion light microscopy. Plasmodium falciparum 
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parasites were counted per 200 leukocytes to estimate the 
parasite density per microlitre of blood. All blood smears 
were read by two independent microscopists.
Extraction, purification and analysis of parasite RNA
Thirty-five day 0 and day 7 paired trizol preserved sam-
ples were selected based on their antibody titres against 
a gametocyte specific antigen Pfs48/45-6C (19). The 
Pfs48/45 titres were obtained during an experiment 
that will be published separately and the selected sam-
ples included sero negative, low seropositive and high 
sero positive relative to a positive control. RNA was iso-
lated from samples (100 μl packed blood cells) using the 
Quick RNA MiniPrep kit (Zymo Research) following the 
manufacturer’s protocol, which included an on column 
DNaseI treatment prior to elution with 36  μl of elution 
buffer. Eight microlitres of RNA extracted from the day 
0 and day 7 blood samples were converted into 20 μl of 
cDNA using a Qiagen Omni script Reverse Transcriptase 
kit (Qiagen) and oligo-dT primers. To check for genomic 
DNA contamination after RNA extraction, conventional 
PCR was performed on all RNA (4 µl) samples and 2 µl 
of their corresponding cDNA samples diluted 1:10. Con-
trols used in these PCR reactions were P. falciparum and 
Homo sapiens genomic DNA as well as a no template 
control (NTC) from the cDNA conversion reaction. 
Pfs48/45 primers (Additional file 1) were used for the day 
0 samples and human blood group O genotyping prim-
ers as described by Tun et al. [27] (Additional file 1) were 
used for the day 7 samples that, except for one patient, 
were no longer positive for P. falciparum asexual para-
sites by microscopy. Real time (RT)-PCR was only car-
ried out on cDNA samples after confirming that the PCR 
products run on 2% ethidium bromide stained agarose 
gels did not have amplified products in wells with the 
NTC and the RNA samples but there were products in 
the cDNA and 3D7 gDNA samples. A two-step SYBR 
Green 1 non-quantitative real time reverse transcrip-
tion-PCR (RT-PCR) was performed on the P. falciparum 
cDNA isolated from the day 0 and day 7 blood samples.
Gametocyte carriage was assessed using Pfs25 tran-
script levels. Validation of the Pfs25 mRNA primer set 
(Additional file  1) was performed on cDNA converted 
Fig. 1 A geographic map showing location of the study sites in Southern Ghana
Table 1 Background data of study participants
a Asexual parasite prevalence
b G6PD Deficient: A376G plus one or more (G202A, G680T or T968C) mutation. 
Only 105 out of 112 could be genotyped
Parameter Values
Age range (months) 4–156
Geometric mean age (months) 52.18
D0 parasite prevalence by microscopya 72/96
D0 parasitaemia range (per µl of blood)a 400–648,080
Geometric mean D0 parasitaemia (per µl of blood)a 20,319
D7 parasite prevalence by microscopya 1/96
D0 gametocyte prevalence by microscopy 3/96
D7 gametocyte prevalence by microscopy 2/96
D0 parasite prevalence by PCR 96/96
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RNA extracted from cultured NF54 stage IV and V 
gametocytes using the same methods describe above for 
the patient samples. The cDNA was diluted 1:20 with 
subsequent twofold serial dilution until 1: 640 and each 
dilution was tested in triplicate using a Pfs25 primer 
concentration of 300 nM and the fast SYBR® Green 2X 
master mix RT-PCR kit (Applied BioSystems). The reac-
tion was run on an Applied Biosystems One-step Plus 
RT-PCR machine and the cycling conditions were 95 °C 
for 20 s, 40 cycles of 95 °C for 3 s and 60 °C for 30 s. A 
melt curve was performed on the final product. Applied 
Biosystems StepOnePlus software was used to determine 
the threshold cycle (CT) for each cDNA concentration 
and the data used to plot a standard curve (Additional 
file 2). The CT values of the no template control was used 
to determine the cut-off for the presence or absence of 
gametocytes. The patient samples were tested in tripli-
cate using Fast SYBR® Green 2X master mix RT-PCR kit 
(Applied BioSystems). Two microlitres of cDNA diluted 
20 fold (equivalent to 0.11  µl of packed blood cells) in 
a total reaction volume of 20  µl. The same fast SYBR® 
Green RT-PCR conditions described above were used 
and the data analysed using Applied Biosystems StepO-
nePlus software.
Extraction of parasite DNA
Genomic DNA was extracted from two 3 mm punches of 
dried blood blots using Saponin-Chelex extraction [28]. 
Briefly, the blood stained filter paper discs for each sam-
ple (day 0 and day 7) were incubated in 1.5 ml containing 
1120 μl of 0.5% saponin/PBS solution overnight at room 
temperature on a shaking incubator. After the overnight 
incubation, the supernatant was discarded and the sam-
ples washed twice with 1  ml PBS, followed by a high-
speed centrifugation at 10,000×g. Finally, 150 μl of a 6% 
Chelex (Sigma-Aldrich, USA) in DNase/RNase free water 
was added to the washed samples and incubated at 95 °C 
for 5 min to extract DNA from the samples. After a final 
high-speed centrifugation, the supernatant containing 
the DNA was stored at −20  °C until used for the geno-
typing amplification reactions.
Molecular identification and genotyping
To distinguish three major allelic families (K1, MAD 20, 
and RO33) block 2 of msp1 and the two allelic families 
(FC27 and IC3D7) central polymorphic region of msp2, 
nested PCR was performed using family specific prim-
ers [29] shown in Additional file 1. All amplification reac-
tions were carried out in a final volume of 15 μl. The outer 
PCR reaction mix contained 200 nM dNTP, 2 mM MgCl2. 
133  nM of each primer, and 0.5 unit of One Taq DNA 
polymerase (New England BioLab) in addition to 4  μl 
(about 0.25 μl of whole blood) of genomic DNA (gDNA) 
template. In the nested reaction, 0.5 μl of the outer PCR 
product was used as template in a PCR reaction mixture 
containing 200 nM dNTP, 1.8 mM MgCl2. 200 nM of each 
primer and 0.5 unit of One Taq DNA polymerase. Each 
amplification profile consisted of initial denaturation at 
94 °C for 3 min, followed by 30 cycles at 94 °C for 1 min; 
50–59 °C (depending on the primer pair annealing temper-
atures) for 35 s, and 68 °C for 2.5 min; with final extension 
at 68 °C for 3 min. The PCR reaction mixtures were run on 
a thermal cycler (MJ Research Tetrad PTC-225 Thermal 
Cycler, USA). Allelic specific positive controls 3D7, K1, 
HB3 and RO33 gDNA and no template negative controls 
were included in each set of reactions. PCR products were 
separated using 2% ethidium bromide-stained agarose gels 
respectively and visualized under UV illumination.
Multiplicity of infection
The multiplicity of infection (MOI) or number of geno-
types per infection was calculated by dividing the total 
number of msp1 or msp2 fragments detected by the 
number of samples positive for the same marker. Samples 
with more than one genotype were considered as con-
taining multiclonal infections while the presence of a sin-
gle allele was considered as clonal infection.
G6PD genotyping
PCR based G6PD genotyping was performed on the 
extracted DNA using primers listed in Carter, et  al. as 
previously reported [30]). The A376G mutation was 
characterized in each DNA sample using restriction frag-
ment length polymorphism (RFLP) by digesting the 376 
PCR amplicon with 1 unit of FOKI restriction enzyme 
at 37 °C for an hour. Only samples with the 376G geno-
type where further analyzed for three other sub-Saharan 
African cDNA mutations, G202A, G680T and T968C 
also using RFLP as described in our previous work [31]. 
The G202A PCR amplicon was digested with NlaIII 
restriction enzyme, the G680T amplicon was digested 
with BstNI restriction enzyme and the T968C amplicon 
digested with NciI restriction enzyme for 1  h at 37  °C. 
All the PCR fragments and the digested fragments were 
viewed under UV light after resolving on a 2% agarose gel 
containing 0.5 µg/ml ethidium bromide.
Data analysis
Data were entered and analysed using Excel and Graph-
Pad Prism version 7.0. The Shapiro–Wilk normality used 
to determine if the data was normally distributed. The 
data was not normally distributed, thus the Mann–Whit-
ney test was used to determine relationships between 
age and PD, MOI and Pfs25 RT-PCR CT values using 
GraphPad Prism v7.0. The geometric means and other 
column statistics were obtained using GraphPad Prism 
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v7.0. Proportion was used to present the distribution of 
different allelic families. The frequency of msp1 and msp2 
family alleles was calculated as the ratio of the number of 
PCR products obtained for each family to the total num-
ber of gene specific PCR products identified. A sample 
was classified as harboring a multiclonal infection when 
more than one amplified fragment was obtained during 
either or both the msp1 and msp2 genotyping. The mean 
MOI was calculated as a total number of P. falciparum 
genotypes detected per total number of positive samples. 
Linear regression was used to determine the relationship 
between MOI and day 0 and day 7 CT values obtained 
during the Pfs25 real time reverse transcriptase PCR. 
Statistical significance was defined as P ≤ 0.05.
Results
Asexual and gametocyte parasite density in the study par-
ticipants were monitored by microscopy on day 0 and day 
7, 4 days after a 3 day ACT regimen. All the children were 
PCR positive for P. falciparum after MSP genotyping, how-
ever after the thick smears prepared by the hospital labo-
ratory staff were re-read by highly trained microscopists, 
only 72 of the children had microscopy confirmed para-
sites on day 0. The geometric mean of P. falciparum para-
site density recorded by microscopy for the 96 participants 
that returned for the follow up visit was 20.319/µl blood 
(95% CI 13.568–30.428) at day 0. Three samples were 
positive for P. falciparum by MSP genotyping on day 7, 
although only one sample had microscopy confirmed asex-
ual parasites with a density 76,080/µl.
Three samples were positive for gametocytes by 
microscopy on day 0 with a mean gametocyte density 
of 93.33 (SEM 35.28) two of these samples remained 
gametocytaemic on day 7, with gametocyte densities of 
320 and 400/µl. Plasmodium falciparum parasite car-
riage measured by PCR analysis of the MSP2 and MSP1 
genes revealed that all the day 0 samples were positive 
for P. falciparum parasites but only three day 7 samples 
were positive. MSP genotyping revealed one day 7 sam-
ple to be a recrudescent infection and the other two as 
new infections. The geometric mean participant age was 
52.18 (95% CI 44.74–60.86) months, with a range from 
4  months through to 156  months. No significant rela-
tionship between age and PD was identified in this study 
(Additional file  3). The prevalence of G6DP deficiency 
was estimated at 4.76% (5/105) and consisting of three 
hemizygous A- males and two AA- heterozygous females 
in the entire study population, however no data was 
available for seven of the children (Table 1).
Submicroscopic gametocytes
The Pfs25 RT-PCR was used to screen for submicroscopic 
levels of gametocytes in 35 trizol preserved samples that 
were selected to represent a range of titres for gametocyte 
specific antigen Pfs48/45-6C (Additional file 4). Although 
Pfs25 mRNA is not translated until uptake by a mosquito, 
the transcript is expressed and stored in mature female 
gametocytes [32] and it has been developed as a sensitive 
and specific marker for circulating mature gametocytes 
[33, 34]. Twenty-seven of the day 0 samples were classi-
fied as positive using a CT cut off of 35 (77%) (Table 2; 
Additional file 4). Eighteen of the 35 samples were game-
tocyte positive on both days (51.4%), including the sam-
ple that was gametocyte positive by microscopy on day 0 
and day 7. Three samples were identified that were game-
tocyte negative on day 0 but gametocyte positive on day 
7, making the total number of gametocyte positive sam-
ples for day 7 equal 21 (60%). Four samples which were 
gametocyte negative on day 0 and remained gametocyte 
negative on day 7 (Table  2; Additional file  4). Interest-
ingly, significantly more children above the age of 5 years 
had submicroscopic gametocytes on day 7 (Additional 
file 3).
Genetic diversity and multiplicity of infection
Plasmodium falciparum genes, which show extensive 
polymorphisms, such as merozoite surface proteins 1 
(msp1) and 2 (msp2) can be used as markers to study 
parasite genetic diversity and multiplicity of infection 
(MOI) [35]. Msp1 Block 2 is the most polymorphic 
region of the gene and is grouped into three allelic fami-
lies namely K1, MAD 20, and RO33 type, while in the 
msp2 gene block 3 is the most polymorphic region and 
consists of FC27 and 3D7 families [36]. In total, PCR 
products were detected using at least one msp1 and 
msp2 family specific primer set in 86 of the 96 samples 
(Table  3). Only 12 samples had a single band for both 
msp1 and msp2, indicating that less than 14% of the sub-
jects had monoclonal infections (as predicted by msp 
genotyping). The remaining samples had a range of com-
binations of the different allelic families. For msp1, the 
frequency of MAD20 and K1 family alleles were simi-
lar and higher than the R033 alleles (Fig. 2a). Of the 88 
samples with PCR products for msp1, 62 had at least one 
K1 allele, 60 had at least one MAD20 allele and 52 had 
at least one R033 allele. Thirty-five percent of the sub-
jects were multiply infected with parasites from all three 
Table 2 RT-PCR detection of submicroscopic gametocytes
All cDNA samples were positive for a human blood group gene by RT‑PCR. D0 
Samples negative for Pfs25 were RT‑PCR positive for KAHRP
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msp1 families. Additional diversity was also evident 
within the K1 and MAD20 families, as eight subjects had 
two distinct MAD20 alleles and five samples had two 
distinct K1 alleles (Fig.  3a). Five samples had 4 distinct 
msp1 alleles, 30 had 3 alleles, and 24 had 2 alleles, while 
29 were monoclonal for msp1 (Fig.  3a). Fifty-nine per-
cent of the msp1 monoclonal infections belonged to the 
Table 3 Prevalence of clonal parasite infections in the samples
a Parasite population within a sample as determined by MSP1 and MSP2 family specific PCR. Two samples which failed msp2 genotyping PCR yielded products in 
msp1 genotyping and as such there were 86 samples common to both genotyping procedures. The numbers in brackets represents the total number of samples in 
group
Parameter RO33 MAD20 K1 3D7 FC27 Clonala
msp1 (88) 13 7 9 29
msp2 (94) 15 18 33
msp1 + msp2 (86) 4 5 3 7 5 12
Fig. 2 Representation of msp1 (a) and msp2 (b) allele families in 
the study population. The distribution of parasites within the major 
families and their combinations in patient samples are shown. The 
numbers in brackets represents the total number of samples that 
contained at least one parasite belonging to the allelic family
Fig. 3 Prevalence and multiplicity of infection of msp1 (a) and msp2 
(b) alleles. Each distinct amplicon produced by msp1 or msp2 family 
specific PCR represents a particular parasite clone. The number of 
samples that contained distinct alleles (color coded and labelled 1 
through 6) for a msp1 (msp1 MOI) or each of the three msp1 families 
(RO33, MAD20 or K1) or b msp2 (msp2 MOI) or each of the two msp 
families (3D7 or FC27) are plotted
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R033 family (13 of the 29). The geometric mean MOI for 
msp1 in the study was 1.90 (95% CI 1.71–2.11).
For msp2, 77 of the 94 samples with msp2 PCR prod-
ucts had at least one FC27 allele and 68 had at least one 
3D7 allele. Again most samples were polyclonal, contain-
ing alleles from both families (51 of 94 samples) (Fig. 3b). 
As with msp2, some samples also contained multiple alleles 
within one msp2 family (Fig. 3b); with one sample contain-
ing six distinct msp2 alleles. Only thirty-three of the 94 
PCR-positive msp2 samples were monoclonal for msp2. The 
geometric mean of msp2 MOI was 1.88 (95% CI 1.68–2.10).
Combining genotyping results, the study identified 
only 12 samples that carried a parasite population with 
a single allele for both msp1 and msp2 (Table 3), suggest-
ing that the clonal parasite population estimated solely by 
msp1 genotyping is overestimated by 58.6% (17/29) and 
63.6% (21/33) when msp2 genotyping is used exclusively. 
Two samples that were multiclonal by msp1 genotyp-
ing did not have any msp2 data and eight samples, three 
clonal and five multiclonal identified by msp2 genotyp-
ing did not have msp1 data. No significant correlation 
between the MOI for either msp1 or msp2 and submi-
croscopic gametocyte prevalence was found in this study 
(Additional file 3).
Discussion
The high prevalence (77%) of mature gametocytes 
detected by RT-PCR in the day 0 samples (Table  1) is 
consistent with the high malaria transmission rates 
observed in southern coastal Ghana [25] and is similar 
to studies in other regions of Africa using Pfs25 RT-PCR 
[2, 16, 37–40]. The continued persistence of gametocytes 
in 60% of the patients even after the clearance of asexual 
parasites with ACT drug treatment, including 2 of the 3 
patients with microscopically detectable gametocytes 
on day 7, highlights the lack of efficacy of ACT against 
mature sexual stage parasites [31, 38, 41, 42] and the need 
to develop new strategies to block the spread of malaria.
Although age was not significantly associated with 
submicroscopic gametocytes levels on day 0 (Additional 
file  3), older patients had a significantly higher preva-
lence of submicroscopic gametocytes on day 7 compared 
with the younger children due to them having a lower 
mean CT value for Pfs25 real time reverse transcriptase 
PCR value (Additional file  3), suggesting an age associ-
ated decrease in gametocyte clearance following ACT. 
A larger study that includes a wider age range of patients 
would be needed to confirm this and to begin to define 
the contributing factors, such as the role of a maturing 
immune response in gametocyte clearance. The acquisi-
tion of immunity to clinical malaria is well established 
[43], but immune mediated clearance of gametocytes has 
been more difficult to demonstrate [44].
Primaquine (PQ) is currently the only WHO approved 
drug with potent transmission-blocking activity that 
targets mature P. falciparum gametocytes [45–47]. As 
Ghana targets to move beyond the malaria control phase 
into the pre elimination phase, there is a possibility of 
implementing PQ with first-line anti-malarial ACT to 
reduce gametocyte prevalence in Ghana as is on-going 
in some countries in the elimination and pre elimination 
phase [45]. The prevalence and extent of g6pd deficiency 
is a major concern for malaria eradication programmes, 
where they plan to use PQ as a gametocidal agent as 
although a single low dose of PQ has been suggested to 
be well tolerated in G6PD deficient malaria patients, PQ 
has been found at certain concentrations and in certain 
instances to cause RBC lysis in g6pd deficient individu-
als [48–50]. The 4.7% incidence of g6pd deficiency identi-
fied in this study was similar to another study conducted 
in 2015 in two different communities along the coast of 
Ghana where G6PD deficiency was 5.9% in hemizygous 
males and homozygous females [31]. The prevalence 
of this population needs to be taken into consideration 
when evaluating the use of primaquine or other 8-amino-
quinolines as gametocidal agents in this region.
Multiplicity of infection within the allelic families 
reduced clonality of the parasite population from 37.5 
to 33% in msp1 and 46 to 35% in msp2 (Fig. 2; Table 3) 
and it possible that even higher MOIs would be identi-
fied within the allelic families if a more sensitive sizing 
technique such as capillary electrophoresis was used 
instead of agarose gel electrophoresis. High parasite MOI 
(≥2) has been associated with increased parasite den-
sity, although whether this is related to parasite survival 
or increased production was not directly evaluated [51]. 
Multiclonal infections also enhance the chance of hete-
rozygous mating after the parasites have been taken up in 
a blood meal of a mosquito [4–7]. Fertilization between 
two distinct parasites provides the opportunity for chro-
mosome recombination during meiosis, which enhances 
genetic diversity in the parasite population. Geometric 
mean MOIs for msp1 and msp2 of 1.90 and 1.88 were 
slightly lower than obtained in an earlier report from the 
middle belt of Ghana where MOI was 2.3 in July/August, 
[52] but similar to another report of MOI in southern 
Ghana which was 1.93 [24] and 1.3 in 2013 [53]. This dis-
crepancy may be due to differences in ecological zones 
[54], malaria transmission intensity [36, 55] and/or the 
treatment-seeking behaviour of malaria patients within 
the various population [56, 57].
Even at these relatively low MOIs the majority of the 
samples (86%) contained more than one msp1 or msp2 
allele (Fig.  3) indicating the potential for cross-fertili-
zation once gametocytes are taken up by a mosquito. 
Gametocytes prevalence was not associated with MOI, 
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indicating that multiply infected individuals were just as 
likely to be gametocyte carriers as those with monoclonal 
infections. The combination of high gametocyte preva-
lence and multiclonal infections sets the stage for mating 
between two distinct parasite lines and further enhanc-
ing parasite diversity.
Limitations
Although all the volunteers were prescribed and admin-
istered received the same ACT, artemether-lumefantrine, 
they did so in their respective homes and as such compli-
ance to the prescribed regimen could have been compro-
mised. Such non-conformity in prescribed drug intake 
could influence the prevalence of both asexual and sexual 
stage parasites. This scenario reflects what happens in the 
community, where non-compliance can be a major obsta-
cle for malaria control programmes.
Conclusion
This study provides critical information on factors that 
influence malaria transmission such as the presence of 
submicroscopic levels of gametocytes in 77% of the chil-
dren on day 0 which persisted in 60% of the children on 
day 7. The high prevalence of gametocytes and multi-
clonal infections (86%) in the children suggests there is 
ample opportunity for recombination during fertiliza-
tion, which would enhance genetic diversity and could 
contribute to the emergence of drug resistant parasites. 
Older children were more likely to have submicroscopic 
gametocytes on day 7 suggesting an age associated 
decrease in gametocyte clearance following ACT treat-
ment. The high prevalence of submicroscopic gameto-
cytes levels is consistent with other studies and it will be 
important to monitor drug resistance, particularly ACT 
clearance in future studies.
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